ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
Lobectomy for Clincial Stage T1N0M0 Solid NSCLC by VATS Versus Thoracotomy
1 other identifier
interventional
1,086
1 country
1
Brief Summary
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedStudy Start
First participant enrolled
February 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2028
ExpectedJuly 21, 2023
July 1, 2023
3 years
December 19, 2018
July 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease-free survival
Disease-free survival means the period after surgery when no disease can be detected.
3 years after the surgery
Secondary Outcomes (3)
Overall survival
3 years after the surgery
Rate of patients with perioperative complication
1 month after surgery
Pain degree and quality of life
1 years after the surgery
Study Arms (2)
VATS
EXPERIMENTALVideo-assisted thoracoscopic surgery
Thoracotomy
ACTIVE COMPARATOROpen surgery
Interventions
Eligibility Criteria
You may qualify if:
- Clinical stage T1N0M0 and surgical resectable.
- Solid appearance on computed tomography scan.
- Age 18 to 75 year.
- Signed the informed consent form.
You may not qualify if:
- Not NSCLC in pathological analysis.
- Not lobectomy or sublobar resection.
- History of other malignant tumors within 5 years.
- History of thoracic surgery or unsuitable for VATS.
- Previous radiation or chemotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Fudan University Shanghai Cancer Center
Shanghai, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shanghai Cancer Center Chen, Ph.D
Shanghai Cancer Center
Central Study Contacts
Haiquan Chen, Ph.D
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 19, 2018
First Posted
December 24, 2018
Study Start
February 9, 2022
Primary Completion
February 9, 2025
Study Completion (Estimated)
February 9, 2028
Last Updated
July 21, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Every 3 months after the study begin.
Study Protocol, Inform Consent Form, Clinical Study Report would be shared every 3 months after the study begin.